117 related articles for article (PubMed ID: 10980175)
1. In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host.
Rebuck JA; Olsen KM; Fey PD; Bergman KL; Rupp ME
J Antimicrob Chemother; 2000 Sep; 46(3):461-4. PubMed ID: 10980175
[TBL] [Abstract][Full Text] [Related]
2. Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam.
Shahi SK; Singh VK; Kumar A
PLoS One; 2013; 8(7):e68234. PubMed ID: 23861873
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Suto S; Zagar Z
Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
[TBL] [Abstract][Full Text] [Related]
4. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
Jacoby GA; Carreras I
Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623
[TBL] [Abstract][Full Text] [Related]
5. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Burgess DS; Hall RG
Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
[TBL] [Abstract][Full Text] [Related]
6. The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli.
Wu N; Chen BY; Tian SF; Chu YZ
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():45. PubMed ID: 25213463
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
[TBL] [Abstract][Full Text] [Related]
8. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics.
Matar GM; Al Khodor S; El-Zaatari M; Uwaydah M
Ann Trop Med Parasitol; 2005 Jun; 99(4):413-7. PubMed ID: 15949189
[TBL] [Abstract][Full Text] [Related]
11. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Thomson KS; Moland ES
Antimicrob Agents Chemother; 2001 Dec; 45(12):3548-54. PubMed ID: 11709338
[TBL] [Abstract][Full Text] [Related]
12. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility.
Manoharan A; Premalatha K; Chatterjee S; Mathai D;
Indian J Med Microbiol; 2011; 29(2):161-4. PubMed ID: 21654112
[TBL] [Abstract][Full Text] [Related]
13. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
Randegger CC; Hächler H
J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure effects of cefepime and cefpirome on isogenic Escherichia coli hosts producing SHV-extended-spectrum beta-lactamases.
Bedenic B; Vranes J
J Chemother; 2003 Aug; 15(4):342-9. PubMed ID: 12962362
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
18. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.
Yagi T; Kurokawa H; Shibata N; Shibayama K; Arakawa Y
FEMS Microbiol Lett; 2000 Mar; 184(1):53-6. PubMed ID: 10689165
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
Raveh D; Yinnon AM; Broide E; Rudensky B
Chemotherapy; 2007; 53(3):185-9. PubMed ID: 17347564
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
